Organisation paid for research Program year 2024 Source: CMS Open Payments

Bellevue Dermatology

Neither a doctor nor a teaching hospital

Research payments

$40,387

7 payments

Through program year 2024, Bellevue Dermatology is reported as receiving $40,387 in research payments, across 7 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2024	Research	$21,815	3
2023	Research	$18,260	3
2020	Research	$312	1

Breakdown

Who paid Research payments · program years 2020–2024

E.R. Squibb & Sons, L.L.C. $40,075 6 payments
Celgene Corporation $312 1 payment

Studies the money was for Research payments · program years 2020–2024

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting $24,624 4 payments
A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED STUDY EVALUTING IMPACT OF DEUCRAVACITINIB ON QoL, EFFICACY AND SAFETY IN PATIENTS WITH PLAQUE PSORIASIS AND IMPAIRED HEALTH-RELATED QUALITY OF LIFE $15,451 2 payments
A Phase 3, Multicenter, Randomized, Placebo-Controlled, Double Blind-Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis $312 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.